Skip to main content
Clinical Trials/NCT05679063
NCT05679063
Completed
Not Applicable

Therapeutic Exercise and Education in Neurophysiology of Pain in the Quality of Life of Women With Endometriosis: Clinical Trial

University of Valladolid1 site in 1 country40 target enrollmentDecember 29, 2022
ConditionsEndometriosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Endometriosis
Sponsor
University of Valladolid
Enrollment
40
Locations
1
Primary Endpoint
Changes in quality of life perception assessed using EUROQuOL 5D - 5L
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

The objective of this study will be to evaluate treatment using ET exercise and pain education in women with endometriosis to achieve improvement in quality of life.

Detailed Description

A study will be carried out whose objective is to improve the quality of life in women with endometriosis through a program of therapeutic exercise and education in the neurophysiology of pain. Also as secondary variables will be observed: menstrual symptoms, sexual function, and abdominal wall thickness measured with ultrasound.

Registry
clinicaltrials.gov
Start Date
December 29, 2022
End Date
May 1, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rebeca Abril Coello

Principal investigator

University of Valladolid

Eligibility Criteria

Inclusion Criteria

  • Women of reproductive age between 18 and 45 years.
  • Women with a medical diagnosis of endometriosis.
  • Women with visual analog scale (EVA) between 4 and 10 (moderate-severe pain) during the last 3 months in the suprapubic area, abdomen or perineum both continuously and intermittently.

Exclusion Criteria

  • Women who must have surgery during the study.
  • Women who have undergone abdominal or pelvic surgery or who have given birth (vaginal or cesarean) in the last 6 months.
  • Women who are pregnant or planning a pregnancy.
  • Women with uncorrected pacemakers or coagulopathies, severe comorbid disorder, cancer (in the last 5 years or at present), severe mental disorders, or neuropathies affecting the nerves of the pelvis or lower extremities.
  • Physiotherapy treatments or treatments related to pathology or study areas 15 days prior to the beginning of the study.
  • Variations in medication in the 3 months prior to the start of the stud

Outcomes

Primary Outcomes

Changes in quality of life perception assessed using EUROQuOL 5D - 5L

Time Frame: Baseline, Up to 1 month, Up to 3 months.

The scale will be administered by one of the researchers, This scale covers five dimensions, each of which is assigned a score from 1 to 5, and with these scores, a code is obtained that indicates the person's quality of life. High values indicate poor quality of life.

Secondary Outcomes

  • Abdominal wall muscle thickness(Baseline, Up to 1 month, Up to 3 months)
  • Sexual Function assessed usinf Female Sexual Function Index (IFSF)(Baseline, Up to 1 month, Up to 3 months)
  • Symptoms associated with menstruation assessed using CVM-22 (quality of life related to menstruation)(Baseline, up to 1 month, up to 3 months)

Study Sites (1)

Loading locations...

Similar Trials